Evidium key facts
as of Oct 2026- Developer of a clinical intelligence platform designed to make medical knowledge computational and transparent for data-driven healthcare.
- Evidium is valued at approximately $52.7M as of Oct 2026 (last reported valuation).
- It has raised $33.2M; the latest was Later Stage VC ($22.0M) in Nov 2025.
- Notable investors include SeedFolio, Sage Hill Investors, Interwoven Ventures, United Healthcare Services, Hammer Ventures — 13 tracked in total.
- Status: Privately Held (backing).
Evidium's last reported valuation, Nov 2025. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch Evidium: the Monday email on marks, rounds and moves
Evidium funding rounds
No funding rounds for Evidium are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Evidium
13+Membership and data by Private Market View
Evidium valuation
Evidium's last reported valuation was $52.7 million in Nov 2025. No priced round, secondary trade or fund mark has surfaced since.
Evidium investors
13 investors are on record for Evidium, including SeedFolio, Sage Hill Investors, Interwoven Ventures and United Healthcare Services.
About Evidium
Developer of a clinical intelligence platform designed to make medical knowledge computational and transparent for data-driven healthcare. The company offers precision tools that integrate clinical and financial data to connect care and coverage, enabling healthcare providers and payors to predict patient trajectories and costs, improve clinical outcomes, and support informed decision-making.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2020
- Employees
- 31
- Website
- evidium.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.